Adenosine Impurity 25 | CAS 22837-43-0 - Request Quote
Adenosine Impurity 25
| SZ CAT No: | SZ-A102066 |
| CAS No | 22837-43-0 |
| Mol.F. | C10H13N5O4 |
| Mol.Wt. | 267.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Adenosine Impurity 25 is chemically 2-Amino-9-((2R,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,9-dihydro-6H-purin-6-one. Adenosine Impurity 25 is supplied with detailed characterization data compliant with regulatory guideline. Adenosine Impurity 25 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Adenosine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 22837-43-0
Purchase 22837-43-0
Order 22837-43-0
Enquire 22837-43-0
price of 22837-43-0
22837-43-0 Supplier
22837-43-0 Manufacturer
22837-43-0 Exporter
buy high quality Adenosine Impurity 25
Purchase Adenosine Impurity 25
Adenosine Impurity 25 suppliers
Adenosine Impurity 25 manufacturers
Adenosine Impurity 25 price
Order Adenosine Impurity 25
Enquire Adenosine Impurity 25
Adenosine Impurity 25 cost
Adenosine Impurity 25 Supplier
Adenosine Impurity 25 Distributor
Adenosine Impurity 25 for Method Validation
Adenosine Reference Standard
Adenosine Impurity 25 for ANDA Filing
Adenosine Impurity 25 for Forced Degradation Studies
Adenosine Impurity 25 Identification Standards
Adenosine Impurity 25 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.